Vetter inaugurates comprehensive site in Germany
Integrated location unites production facilities, packaging plant and laboratory
The comprehensive Ravensburg Vetter South site was officially inaugurated on September 25. The past six years have seen Vetter invest significantly into the site, with a total area of some 80,000 m2 (862,000 ft2), that now includes state-of-the-art facilities for the aseptic filling and packaging of injectable drugs. The location features three buildings: a cutting-edge production facility, a final assembly and packaging plant, and a laboratory for ongoing production-related analyses. The company’s investment at the Ravensburg South location to date totals some 150 million Euros, with a further, ongoing investment of 50 million Euros in expanded pharmaceutical production now underway.
The newly inaugurated Vetter location is one of the most innovative pharmaceutical production sites in the world, boasting maximum production automation, the use of RABS (Restricted Access Barrier Systems), central material supply with optimized material flows and two independent filling lines.
The two filling lines were the first segments of the expanded production site to begin operating in early 2007, after a mere 36 months of construction. Liquid and freeze-dried drugs are filled into Vetter Lyo-Ject® and V-LK® dual-chamber systems on the RVS 1 Mulitiformat Line and into cartridges and vials on the RVS 2 Combination Line.
The facility was designed and built with the ongoing expansion in mind, allowing production to continue without any impact from the construction work. Currently, final preparations are being made for a third production line. All work on this project is scheduled for completion by mid 2011.
Other news from the department manufacturing
